Explicit oncogenicity criteria review reference
SOP and expert criteria reviews are references. The historical MTB functional interpretation is retained as a distinct proxy, never a benign-germline negative control.
Evaluation results
0 evaluations · 0 results. Different protocols are not a single leaderboard.
Applied filters: All linked evaluations
No evaluations linked in this release.
Source checking is not independent reproduction. Release 2026-09-30-e37e3ab1284d.
Applicable tests and references
Applicability is distinct from a completed evaluation.
- OncoVI three-class assessment: Guideline SOP variants · Proposed association
- OncoVI three-class assessment: Erlangen MTB variants · Proposed association
- OncoVI three-class assessment: MTB selected expert reassessment · Proposed association
- OncoVI three-class assessment: ClinVar April 2025 oncogenicity assertions · Proposed association
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
9 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| attributes.applicability source_supported Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.baseline_type conventional_workflow Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| description SOP and expert criteria reviews are references. The historical MTB functional interpretation is retained as a distinct proxy, never a benign-germline negative control. Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: applicable to uc-clinical-20260930-oncovi-clinvar-protocol Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: applicable to uc-clinical-20260930-oncovi-expert-protocol Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: applicable to uc-clinical-20260930-oncovi-mtb-protocol Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: applicable to uc-clinical-20260930-oncovi-sop-protocol Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: configuration uc-clinical-20260930-oncovi-manual Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| name Explicit oncogenicity criteria review reference Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology No field-specific location recorded Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
View linked audit checks and correction history
Release 2026-09-30-e37e3ab1284d · Record review: source checked
1 source records and release history
- Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Original source · 2026 final full text in Europe PMC XML
Technical metadata and extraction receipts
Stable ID: uc-clinical-20260930-baseline-oncovi-manual
- areas
- dna-genomes
- contexts
- clinical_research
- baseline type
- conventional_workflow
- applicability
- source_supported
- review
- method: automated_source_review; reviewer: Codex clinical coverage worker; date: 2026-09-30; note: Transcription from inspected primary source. No execution, independent replication or human scientific review.; source id: uc-clinical-20260930-source-oncovi
Related records
- configuration: Manual ClinGen/CGC/VICC oncogenicity review
- applicable to: OncoVI three-class assessment: Guideline SOP variants
- applicable to: OncoVI three-class assessment: Erlangen MTB variants
- applicable to: OncoVI three-class assessment: MTB selected expert reassessment
- applicable to: OncoVI three-class assessment: ClinVar April 2025 oncogenicity assertions